CLEARPOINT NEURO INC (CLPT) Fundamental Analysis & Valuation

NASDAQ:CLPT • US18507C1036

Current stock price

9.07 USD
-0.32 (-3.41%)
At close:
9.07 USD
0 (0%)
After Hours:

This CLPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLPT Profitability Analysis

1.1 Basic Checks

  • In the past year CLPT has reported negative net income.
  • In the past year CLPT has reported a negative cash flow from operations.
  • In the past 5 years CLPT always reported negative net income.
  • In the past 5 years CLPT always reported negative operating cash flow.
CLPT Yearly Net Income VS EBIT VS OCF VS FCFCLPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -38.34%, CLPT is not doing good in the industry: 62.43% of the companies in the same industry are doing better.
  • The Return On Equity of CLPT (-145.77%) is worse than 70.37% of its industry peers.
Industry RankSector Rank
ROA -38.34%
ROE -145.77%
ROIC N/A
ROA(3y)-43.22%
ROA(5y)-34.92%
ROE(3y)-74.46%
ROE(5y)-107.56%
ROIC(3y)N/A
ROIC(5y)N/A
CLPT Yearly ROA, ROE, ROICCLPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • With a decent Gross Margin value of 61.31%, CLPT is doing good in the industry, outperforming 64.02% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLPT has declined.
  • CLPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.19%
GM growth 5Y-1.52%
CLPT Yearly Profit, Operating, Gross MarginsCLPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CLPT Health Analysis

2.1 Basic Checks

  • CLPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CLPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLPT Yearly Shares OutstandingCLPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CLPT Yearly Total Debt VS Total AssetsCLPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -1.02, we must say that CLPT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -1.02, CLPT perfoms like the industry average, outperforming 42.33% of the companies in the same industry.
  • A Debt/Equity ratio of 1.84 is on the high side and indicates that CLPT has dependencies on debt financing.
  • CLPT has a Debt to Equity ratio of 1.84. This is amonst the worse of the industry: CLPT underperforms 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Altman-Z -1.02
ROIC/WACCN/A
WACC10.66%
CLPT Yearly LT Debt VS Equity VS FCFCLPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 6.37 indicates that CLPT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 6.37, CLPT belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
  • A Quick Ratio of 5.56 indicates that CLPT has no problem at all paying its short term obligations.
  • The Quick ratio of CLPT (5.56) is better than 81.48% of its industry peers.
Industry RankSector Rank
Current Ratio 6.37
Quick Ratio 5.56
CLPT Yearly Current Assets VS Current LiabilitesCLPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CLPT Growth Analysis

3.1 Past

  • The earnings per share for CLPT have decreased strongly by -28.57% in the last year.
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.96%

3.2 Future

  • Based on estimates for the next years, CLPT will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.90% on average per year.
  • Based on estimates for the next years, CLPT will show a very strong growth in Revenue. The Revenue will grow by 34.05% on average per year.
EPS Next Y8.77%
EPS Next 2Y13.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.99%
Revenue Next 2Y34.49%
Revenue Next 3YN/A
Revenue Next 5Y34.05%

3.3 Evolution

CLPT Yearly Revenue VS EstimatesCLPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 2031 2032 50M 100M 150M 200M
CLPT Yearly EPS VS EstimatesCLPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. CLPT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLPT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLPT Price Earnings VS Forward Price EarningsCLPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLPT Per share dataCLPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLPT's earnings are expected to grow with 13.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.9%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLPT Dividend Analysis

5.1 Amount

  • CLPT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLPT Fundamentals: All Metrics, Ratios and Statistics

CLEARPOINT NEURO INC

NASDAQ:CLPT (3/27/2026, 8:08:26 PM)

After market: 9.07 0 (0%)

9.07

-0.32 (-3.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-17
Earnings (Next)05-11
Inst Owners45.55%
Inst Owner Change10.97%
Ins Owners4.99%
Ins Owner Change18.29%
Market Cap269.83M
Revenue(TTM)N/A
Net Income(TTM)-23.14M
Analysts82.5
Price Target25.5 (181.15%)
Short Float %12.15%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.94%
Min EPS beat(2)-2.94%
Max EPS beat(2)-2.94%
EPS beat(4)0
Avg EPS beat(4)-15.18%
Min EPS beat(4)-34.8%
Max EPS beat(4)-2.94%
EPS beat(8)3
Avg EPS beat(8)-2.06%
EPS beat(12)5
Avg EPS beat(12)-4.56%
EPS beat(16)8
Avg EPS beat(16)-0.96%
Revenue beat(2)0
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)-1.8%
Revenue beat(4)1
Avg Revenue beat(4)-4.32%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)1.45%
Revenue beat(8)5
Avg Revenue beat(8)-0.07%
Revenue beat(12)6
Avg Revenue beat(12)-1.31%
Revenue beat(16)8
Avg Revenue beat(16)-0.41%
PT rev (1m)-10.71%
PT rev (3m)-13.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.86
P/FCF N/A
P/OCF N/A
P/B 17
P/tB 17
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS1.15
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.34%
ROE -145.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.31%
FCFM N/A
ROA(3y)-43.22%
ROA(5y)-34.92%
ROE(3y)-74.46%
ROE(5y)-107.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.19%
GM growth 5Y-1.52%
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.43%
Cap/Sales 2.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.37
Quick Ratio 5.56
Altman-Z -1.02
F-Score4
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)225.04%
Cap/Depr(5y)185.37%
Cap/Sales(3y)3.62%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30%
EPS Next Y8.77%
EPS Next 2Y13.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.96%
Revenue Next Year46.99%
Revenue Next 2Y34.49%
Revenue Next 3YN/A
Revenue Next 5Y34.05%
EBIT growth 1Y-20.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.42%
EBIT Next 3Y25.55%
EBIT Next 5YN/A
FCF growth 1Y17.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.21%
OCF growth 3YN/A
OCF growth 5YN/A

CLEARPOINT NEURO INC / CLPT Fundamental Analysis FAQ

What is the fundamental rating for CLPT stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLPT.


What is the valuation status of CLEARPOINT NEURO INC (CLPT) stock?

ChartMill assigns a valuation rating of 0 / 10 to CLEARPOINT NEURO INC (CLPT). This can be considered as Overvalued.


What is the profitability of CLPT stock?

CLEARPOINT NEURO INC (CLPT) has a profitability rating of 1 / 10.


What is the financial health of CLEARPOINT NEURO INC (CLPT) stock?

The financial health rating of CLEARPOINT NEURO INC (CLPT) is 4 / 10.